| Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis JR Power, J Alexandre, A Choudhary, B Ozbay, S Hayek, A Asnani, ... Circulation 144 (18), 1521-1523, 2021 | 59 | 2021 |
| State-of-the-art of endomyocardial biopsy on acute myocarditis and chronic inflammatory cardiomyopathy E Ammirati, A Buono, F Moroni, L Gigli, JR Power, M Ciabatti, A Garascia, ... Current cardiology reports 24 (5), 597-609, 2022 | 49 | 2022 |
| Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis LH Lehmann, MB Heckmann, G Bailly, D Finke, A Procureur, JR Power, ... Circulation 148 (6), 473-486, 2023 | 26 | 2023 |
| Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations JR Power, LK Keyt, ED Adler Expert review of cardiovascular therapy 20 (4), 241-251, 2022 | 23 | 2022 |
| Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... Nature Medicine 29 (12), 3100-3110, 2023 | 12 | 2023 |
| Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry J Nowatzke, P Guedeney, N Palaskas, L Lehmann, S Ederhy, H Zhu, ... European Journal of Cancer 177, 197-205, 2022 | 12 | 2022 |
| Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis JR Power, J Alexandre, A Choudhary, B Ozbay, SS Hayek, A Asnani, ... Archives of cardiovascular diseases 115 (5), 315-330, 2022 | 10 | 2022 |
| Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation KR Nakazawa, SP Wengerter, JR Power, RA Lookstein, RO Tadros, ... Journal of Vascular Surgery 66 (1), 151-159, 2017 | 10 | 2017 |
| Trends in vena cava filter insertions and “prophylactic” use JR Power, KR Nakazawa, AG Vouyouka, PL Faries, NN Egorova Journal of Vascular Surgery: Venous and Lymphatic Disorders 6 (5), 592-598. e6, 2018 | 8 | 2018 |
| The impact of surgical care improvement project measures on in-hospital outcomes following elective vascular procedures KR Nakazawa, NN Egorova, JR Power, PL Faries, AG Vouyouka Annals of Vascular Surgery 38, 17-28, 2017 | 8 | 2017 |
| Strengthening value-based medication management in a free clinic for the uninsured: Quality interventions aimed at reducing costs and enhancing adherence RK Arao, YOC Michelle, T Barrett, L Chockalingam, F Khan, A Kumar, ... BMJ open quality 6 (2), e000069, 2017 | 7 | 2017 |
| Reconstruction of “unreconstructable” critical limb ischemia with hybrid techniques JR Power, C Chung, PS Lajos, PL Faries, ML Marin, RO Tadros Journal of Vascular Surgery Cases 2 (1), 10-13, 2016 | 5 | 2016 |
| Vascular medicine and cardio-oncology–A new, evolving clinical frontier J Versmissen, JR Power, J Moslehi Vascular Medicine 25 (3), 205-207, 2020 | 4 | 2020 |
| Predictors of steroid-refractory immune checkpoint inhibitor associated myocarditis J Power, W Meijers, C Fenioux, Y Tamura, A Asnani, J Alexandre, ... European Heart Journal 41 (Supplement_2), ehaa946. 3272, 2020 | 3 | 2020 |
| Femoral access for iliac branched endoprosthesis deployment in patients with a prior bifurcated aortic stent graft RO Tadros, JR Power, SP Wengerter, CYM Png, ML Marin, PL Faries, ... Annals of Vascular Surgery 53, 262-265, 2018 | 3 | 2018 |
| PC038. Influence of Infrarenal Oversizing of Aortic Stent Grafts on Patient Outcomes WE Beckerman, RO Tadros, A Sher, JR Power, CYM Png, M Tardiff, ... Journal of Vascular Surgery 63 (6), 164S, 2016 | 1 | 2016 |
| PO-01-137 ECG AND CT CHARACTERISTICS OF PATIENTS WITH VENTRICULAR ARRHYTHMIAS SUCCESSFULLY ABLATED AT THE ANTERIOR CORONARY SINUS OS J Power, JC Hsu, FT Han, KS Hoffmayer, F Raissi, DE Krummen, GK Feld, ... Heart Rhythm 21 (5), S145-S146, 2024 | | 2024 |
| Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis (vol 29, pg 3100, 2023) C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... NATURE MEDICINE, 2024 | | 2024 |
| Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis C Fenioux, B Abbar, S Boussouar, M Bretagne, JR Power, JJ Moslehi, ... Nature Medicine, 1-1, 2024 | | 2024 |
| Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity JR Power, C Dolladille, A Procureur, SR Ederhy, NL Palaskas, ... medRxiv, 2024.06. 02.24308336, 2024 | | 2024 |
